Vanguard Group Inc. increased its stake in Boston Scientific Corporation by 0.8% in Q3, acquiring an additional 1,115,337 shares. This brings Vanguard’s total ownership to 138,249,447 shares, valued at approximately $13.497 billion and representing 9.33% of the company. Boston Scientific also reported strong Q3 earnings, beating EPS estimates and showing a 15.9% year-over-year revenue increase, with positive guidance for Q1 and FY 2026 despite some analysts lowering price targets.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Vanguard Group Inc. Buys 1,115,337 Shares of Boston Scientific Corporation $BSX
Vanguard Group Inc. increased its stake in Boston Scientific Corporation by 0.8% in Q3, acquiring an additional 1,115,337 shares. This brings Vanguard’s total ownership to 138,249,447 shares, valued at approximately $13.497 billion and representing 9.33% of the company. Boston Scientific also reported strong Q3 earnings, beating EPS estimates and showing a 15.9% year-over-year revenue increase, with positive guidance for Q1 and FY 2026 despite some analysts lowering price targets.